Vaxcyte, Inc. — Director's Dealing 2020

Jun 12, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2020-06-11

Reporting Person: Wassil Jim (Chief Operating Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	14819	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$2.42	2029-12-16	Common Stock (251926)		Direct
Stock Option (right to buy)	$5.35	2030-04-17	Common Stock (82162)		Direct

Footnotes

F1: 1/4 of the shares subject to the option vest on December 1, 2020, and 1/48 of the shares vest monthly thereafter.

F2: 1/4 of the shares subject to the option vest on March 20, 2021, and 1/48 of the shares vest monthly thereafter.